DSM invests in personal care company Sol-Gel Technologies

13-Sep-2006

DSM Venturing, the corporate venturing unit of Royal DSM N.V., announced that it has invested USD 2 mln in Sol-Gel Technologies Ltd., a private early-stage company committed to the development and commercialization of safer and more effective healthcare products. Sol-Gel's technology platform is of interest to DSM for its further development of skin care and dermatology applications as part of its ambitions in the field of Personal Care.

Sol-Gel develops ingredients for sunscreens, anti-acne and anti-ageing products which are based on their proprietary sol-gel technology. This technology enables room temperature entrapment of organic and bioactive molecules in silica glass beads. The ingredients can thereby be safely isolated and their delivery can be controlled, a potentially valuable innovation for the pharmaceutical and cosmetic markets. The company has received exclusive worldwide licenses and patents, plus patents pending, for this technology.

In addition to the investment DSM and Sol-Gel Technologies intend to explore possible joint development activities and other collaborations, not only in the field of Personal Care but also in DSM's strategic markets Animal and Human Nutrition.

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...